Parkside Financial Bank & Trust’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
B
Parkside Financial Bank & Trust's NEO Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its NeoGenomics (NEO) stake by 8.2% in Q1 2026, selling an estimated $158 and leaving 167 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.
Parkside Financial Bank & Trust first reported a position in NEO in Q1 2019 and has held it in 28 quarters since. The position peaked at $18K in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Parkside Financial Bank & Trust held 167 shares of NeoGenomics worth $1.24K as of Q1 2026.
- Parkside Financial Bank & Trust sold 15 NeoGenomics shares in Q1 2026, an estimated $158.
- NeoGenomics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2279 holding.
- Parkside Financial Bank & Trust first reported a position in NeoGenomics in Q1 2019 and has held it in 28 quarters since.
- Parkside Financial Bank & Trust's NeoGenomics position peaked at $18K in Q3 2021.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.